BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 15, 2004
View Archived Issues
Vertex's Deal With Mitsubishi: $33M To Boost HCV Research
Read More
Idun Placement Gets $27M To Progress Liver Therapy
Read More
Alexion, P&G Get FDA Clearance On Pexelizumab Phase III Design
Read More
Theravance Registers For $96M IPO To Advance Drug Programs
Read More
OSI Reports Anticipated Negative Results In Aptosyn Phase III Trial
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
QLT, Atrix Merging In $855M Deal To Grow Pipeline, Build Business
In a transaction valued at $855 million, QLT Inc. and Atrix Laboratories Inc. are merging into a single entity with two marketed products and a multitude of pipeline possibilities. (BioWorld Today)
Read More